Wahed FTSE USA Shariah ETF (HLAL)

Overview

The Wahed FTSE USA Shariah ETF (WSHR) is an exchange-traded fund designed to provide investors with exposure to US equities that comply with Shariah (Islamic) investment principles. It aims to track the performance of the FTSE USA Shariah Index, offering a diversified portfolio of US large and mid-cap stocks that meet specific ethical screening criteria.

Reputation and Reliability

Wahed Invest is a company focused on providing Shariah-compliant financial products and services. While a newer player in the ETF space compared to established giants, they are dedicated to the Islamic finance sector.

Management Expertise

Information regarding specific management team expertise for WSHR is not readily available in public domain, but Wahed Invest generally emphasizes its commitment to Shariah compliance in its product development and oversight.

Goal

To provide investors with a Shariah-compliant investment in the US equity market, seeking to capture the growth potential of US large and mid-cap companies while adhering to Islamic ethical guidelines.

Investment Approach and Strategy

Strategy: The ETF aims to replicate the performance of the FTSE USA Shariah Index. This involves investing in companies that meet the index's screening criteria for Shariah compliance.

Composition The ETF primarily holds stocks of US companies that have undergone a screening process to remove those involved in prohibited industries (e.g., alcohol, pork, gambling, conventional finance) and to ensure their financial ratios meet Shariah standards.

Market Share: As a niche ETF focused on Shariah-compliant investing, WSHR holds a small but significant share within the Islamic finance ETF segment in the US. Specific market share data is not publicly disclosed in granular detail for this specific niche.

Total Net Assets (AUM): 180000000

Key Competitors

• iShares MSCI USA Islamic ETF (ISUS)
• SP Funds S&P 500 Sharia ETF (SPIS)

Competitive Landscape

The competitive landscape for US Shariah-compliant equity ETFs is relatively limited, dominated by a few key players. WSHR's advantage lies in its adherence to the FTSE USA Shariah Index, which may have slightly different constituent companies than other Shariah indices. A disadvantage could be its smaller AUM compared to some competitors, potentially leading to lower liquidity.

Historical Performance: Historical performance data for WSHR shows returns that generally track its benchmark index. Over the past year, it has shown positive returns, but performance can fluctuate with market conditions and the specific composition of Shariah-compliant companies.

Benchmark Comparison: The ETF aims to track the FTSE USA Shariah Index. Its performance is expected to closely mirror that of this index, with minor deviations due to expense ratios and tracking differences.

Expense Ratio: 0.49

Average Trading Volume

The ETF typically trades with an average daily volume that is moderate, suggesting reasonable liquidity for most investors.

Bid-Ask Spread

The bid-ask spread for WSHR is generally tight enough for retail investors to enter and exit positions without significant price concessions.

Market Environment Factors

The ETF is influenced by the overall performance of the US equity market, interest rate policies, and investor sentiment towards ethical and Shariah-compliant investments. Growth in the technology and healthcare sectors, which often have high Shariah-compliant companies, can positively impact its performance.

Growth Trajectory

WSHR has experienced steady growth in AUM since its inception, indicating increasing investor interest in Shariah-compliant US equity exposure. Strategy remains consistent with tracking its benchmark.

Competitive Edge

WSHR's primary competitive edge is its focus on providing a Shariah-compliant investment solution for the US equity market. It caters to a specific investor segment seeking ethical investments that align with Islamic principles. By tracking the FTSE USA Shariah Index, it offers a distinct portfolio of US large and mid-cap companies filtered through rigorous ethical screens, distinguishing it from conventional broad-market ETFs.

Volatility

The ETF's volatility is expected to be similar to that of the broader US equity market, as it holds a diversified basket of US stocks. Historical data suggests moderate volatility.

Market Risk

The primary market risk for WSHR is the inherent volatility of the stock market. Specific to its Shariah compliance, there's a risk that the screening process may exclude certain high-growth companies, potentially leading to underperformance during periods when those excluded sectors or companies are strong market performers.

Ideal Investor Profile

The ideal investor for WSHR is an individual or institution seeking exposure to US equities while adhering to Shariah investment principles. This includes Muslim investors and those who prioritize ethical and socially responsible investing.

Market Risk

WSHR is best suited for long-term investors who want a diversified and Shariah-compliant way to invest in the US stock market and are comfortable with the risks associated with equity investments.

The Wahed FTSE USA Shariah ETF (WSHR) offers a dedicated Shariah-compliant investment into the US equity market, tracking the FTSE USA Shariah Index. It provides diversification across US large and mid-cap companies screened for ethical adherence. While facing limited competition in its niche, WSHR presents a valuable option for ethically conscious investors seeking exposure to American businesses aligned with Islamic principles. Its performance is linked to the broader US market with moderate volatility.

Data Sources:

• ETF Issuer Website (Wahed Invest)
• Financial Data Providers (e.g., Morningstar, ETF.com)
• Index Provider Website (FTSE Russell)

Disclaimers:

This information is for informational purposes only and should not be considered investment advice. Past performance is not indicative of future results. Investors should consult with a qualified financial advisor before making any investment decisions.